⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25861268 | 0.84 | TOP2A (0.41) | — | |
| SCHEMBL25744932 | 0.81 | HCRTR1 (0.30) | — | |
| SCHEMBL25872468 | 0.81 | CSNK2A1 (0.43) | — | |
| SCHEMBL12410803 | 0.78 | CHRM2 (0.37) | — | |
| SCHEMBL24768321 | 0.77 | HCRTR1 (0.31) | — | |
| SCHEMBL24768308 | 0.76 | — | — | |
| SCHEMBL25647875 | 0.74 | TOP2A (0.37) | — | |
| SCHEMBL24768312 | 0.74 | HCRTR1 (0.30) | — | |
| SCHEMBL22431820 | 0.74 | — | — | |
| SCHEMBL25744934 | 0.74 | LRRK2 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11352329-B2 | HIV protease inhibitors | GILEAD SCIENCES, INC. (US) | 2022-06-07 | — | — | US | disclosed |
| US-20210078959-A1 | HIV PROTEASE INHIBITORS | GILEAD SCIENCES, INC. | 2021-03-18 | — | — | US | disclosed |
| US-10774053-B2 | HIV protease inhibitors | GILEAD SCIENCES, INC. (US) | 2020-09-15 | — | — | US | disclosed |
| US-20190210978-A1 | HIV PROTEASE INHIBITORS | GILEAD SCIENCES, INC. (US) | 2019-07-11 | — | — | US | disclosed |